Article info
PostScript
Letter
Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension
- Correspondence to Dr Alexandra J Sinclair, Metabolic Neurology, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, UK; a.b.sinclair{at}bham.ac.uk
Citation
Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension
Publication history
- Received October 30, 2020
- Revised November 25, 2020
- Accepted November 30, 2020
- First published December 24, 2020.
Online issue publication
January 16, 2022
Article Versions
- Previous version (14 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.